Epigenetic activation of α4, β2 and β6 integrins involved in cell migration in trichostatin A-treated Hep3B cells
- 72 Downloads
The epigenetic modulation by histone deacetylase (HDAC) inhibitors including trichostatin A (TSA) has been known to block cell proliferation, induce apoptosis and inhibit cell migration in human cancer cells that represents the potential therapeutic agents for cancers and fibrosis. However, more than 55% of Hep3B cells remained alive after our initial study of 100 nM TSA treatment. To further study the epigenetic modulation and the biological function of newly activated genes by HDAC inhibitor involved in HCC progression and metastasis, we profiled 23 integrin genes including 15α and 8β in TSA-treated Hep3B cells. Six integrins including three down-regulated α6, α10, β8 and three significant up-regulated α4, β2, β6 integrins were revealed after semi-quantitative RT-PCR. To confirm the epigenetic modulation and explore their biological functions, we selected the three significantly up-regulated integrins for confirmation of protein up-regulation, hyperacetylated-histones by ChIP assays, and functional inhibition by specific neutralizing antibodies of integrins. Our results indicated that epigenetic modulation in TSA-treated Hep3B cells up-regulated new integrins including α4, β2 and β6 and reduced migration activities by specific neutralizing antibodies to 61.3%, 42.4% and 34.5%, respectively. Our novel findings provided a better understanding of the epigenetic modulation of integrins and suggested that targeting the epigenetic up-regulated integrins to abrogate the migration activity might be a promising strategy to prevent HCC progression.
Keywordsepigenetic hepatocellular carcinoma Hep3B integrins migration
Unable to display preview. Download preview PDF.
- 18.Nejjari M., Hafdi Z., Gouysse G., Fiorentino M., Beatrix O., Dumortier J., Pourreyron C., Barozzi C., D’errico A., Grigioni W.F., Scoazec J.Y. (2002). Expression, regulation, and function of alpha V integrins in hepatocellular carcinoma: an in vivo and in vitro study. Hepatology 36:418–426CrossRefPubMedGoogle Scholar
- 19.Strait K.A., Dabbas B., Hammond E.H., Warnick C.T., Iistrup S.J., Ford C.D. (2002). Cell cycle blockade and differentiation of ovarian cancer cells by the histone deacetylase inhibitor trichostatin A are associated with changes in p21, Rb, and Id proteins. Mol Cancer Ther 1:1181–1190PubMedGoogle Scholar
- 21.Suzuki T., Yokozaki H., Kuniyasu H., Hayashi K., Naka K., Ono S., Ishikawa T., Tahara E., Yasui W. (2000). Effect of trichostatin A on cell growth and expression of cell cycle- and apoptosis-related molecules in human gastric and oral carcinoma cell lines. Int J Cancer 88:992–997CrossRefPubMedGoogle Scholar
- 25.Choi, H. S., Lee, J. H., Park, J. G., and Lee, Y. I. 2002. Trichostatin A, a histone deacetylase inhibitor, activates the IGFBP-3 promoter by upregulating Sp1 activity in hepatoma cells: alteration of the Sp1/Sp3/HDAC1 multiprotein complex. Biochem Biophys Res Commun 296:1005–1012CrossRefPubMedGoogle Scholar
- 34.Tidswell M., Pachynski R., Wu S.W., Qiu S.Q., Dunham E., Cochran N., Briskin M.J., Kilshaw P.J., Lazarovits A.I., Andrew D.P., Butcher E.C., Yednock T.A., Erle D.J. (1997). Structure-function analysis of the integrin beta 7 subunit: identification of domains involved in adhesion to MAdCAM-1. J Immunol 159:1497–1505PubMedGoogle Scholar
- 35.Torimura T., Ueno T., Kin M., Harada R., Nakamura T., Kawaguchi T., Harada M., Kumashiro R., Watanabe H., Avraham R., Sata M. (2001). Autocrine motility factor enhances hepatoma cell invasion across the basement membrane through activation of beta1 integrins. Hepatology 34:62–71CrossRefPubMedGoogle Scholar